Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
A round up of recent celebrity news – from new ambassadors and patrons, to Amelia Dimoldenberg and Joanna Lumley helping to ...
Lying in my hospital bed in June 1994, I was on a knife-edge. I had no idea what would happen. I was 38. I’d just had a bone ...
The Brighterside of News on MSN19h
New discovery revolutionizes blood cancer treatmentMillions of individuals rely on effective medications to manage diseases like cancer and diabetes. For those with chronic ...
The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...
The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...
Gene therapy using modified blood stem cells helped five adults with severe hemophilia A reach therapeutic levels of clotting ...
The Statesboro community is rallying behind U.S. Army veteran Matthew Kleinsorge, a devoted father of four, as he battles ...
News Medical on MSN57m
Researchers develop T cell growth method that enhances cancer-fighting ability in melanoma modelFindings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the ...
Key Insights Stem's significant retail investors ownership suggests that the key decisions are influenced by... SAN FRANCISCO, January 16, 2025--Stem, Inc. (NYSE: STEM), a global leader in ...
ECTRIMS and EBMT said stem cell transplant can be considered for some with RRMS, such as those who are younger and have less severe disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback